L 55 (Nevirapine Extended-Release 400 mg)
Pill with imprint L 55 is Yellow, Elliptical / Oval and has been identified as Nevirapine Extended-Release 400 mg. It is supplied by Aurobindo Pharma Limited.
Nevirapine is used in the treatment of reduction of perinatal transmission of hiv; hiv infection and belongs to the drug class NNRTIs. There is no proven risk in humans during pregnancy. Nevirapine 400 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for L 55
Nevirapine Extended-Release
- Imprint
- L 55
- Strength
- 400 mg
- Color
- Yellow
- Size
- 19.00 mm
- Shape
- Elliptical / Oval
- Availability
- Prescription only
- Drug Class
- Nnrtis
- Pregnancy Category
- B - No proven risk in humans
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Aurobindo Pharma Limited
- National Drug Code (NDC)
- 65862-0933
- Inactive Ingredients
-
silicon dioxide,
ferric oxide yellow,
hypromellose 2208 (4000 mPa.s),
lactose monohydrate,
sodium stearyl fumarate
Note: Inactive ingredients may vary.
Related Images for "L 55"
More about nevirapine
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Pricing & Coupons
- En Español
- 5 Reviews
- Drug class: NNRTIs
Consumer resources
- Patient Information
- Nevirapine (Advanced Reading)
- Nevirapine Extended-Release Tablets
- Nevirapine Tablets
- Nevirapine Oral Suspension
- Other brands
- Viramune, Viramune XR
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.